Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability (2009 - 2026)

Idexx Laboratories (IDXX) has reported Non-Current Deferred Tax Liability for 18 consecutive years, with $44.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability rose 449.88% year-over-year to $44.6 million; the TTM figure through Mar 2026 stood at $44.6 million (up 449.88% YoY), while the FY2025 annual figure was $31.9 million, down 75.89% from the prior year.
• Non-Current Deferred Tax Liability came in at $44.6 million for Q1 2026 at Idexx Laboratories, up from $31.9 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $132.2 million in Q4 2024, with the low at $2.1 million in Q2 2025.
• Average Non-Current Deferred Tax Liability over 5 years is $18.7 million, with a median of $8.2 million recorded in 2022.
• Across the five-year window, Non-Current Deferred Tax Liability jumped 1727.12% in 2024 and slumped 79.17% in 2025, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $8.2 million in 2022, then dropped by 11.23% to $7.2 million in 2023, then surged by 1727.12% to $132.2 million in 2024, then plunged by 75.89% to $31.9 million in 2025, then jumped by 39.95% to $44.6 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $44.6 million, $31.9 million, and $3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.